Genetics in Medicine - Abstract of article: Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk
Genetics in Medicine (2011) 13, 349–355; doi:10.1097/GIM.0b013e3182091ba4
Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk
Douglas E Levy1,2,3, Stacey D Byfield4, Catherine B Comstock5, Judy E Garber3,6, Sapna Syngal3,6,7, William H Crown4 and Alexandra E Shields1,2,3
- 1arvard/MGH Center for Genomics, Vulnerable Populations and Health Disparities, Boston, Massachusetts
- 2Mongan Institute for Health Policy, Massachusetts General Hospital, Boston, Massachusetts
- 3Department of Medicine, Harvard Medical School, Boston, Massachusetts
- 4i3 Innovus, Medford, Massachusetts
- 5Independent Consultant, Winchester, Massachusetts
- 6Division of Population Science, Dana-Farber Cancer Institute, Brookline, Massachusetts
- 7Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts
- 8i3 Innovus, Ann Arbor, Michigan.
Correspondence: Alexandra E. Shields, PhD, Harvard/MGH Center for Genomics, Vulnerable Populations, and Health Disparities, 50 Staniford Street, 9th floor, Boston, MA 02114. E-mail: firstname.lastname@example.org.
Received 10 August 2010; Accepted 30 November 2010; Published online 23 February 2011.
Disclosure: The authors declare no conflict of interest.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.geneticsinmedicine.org).